Srinivasan Thangathirupathy

Most-cited papers

1. Negative Allosteric Modulators Selective for The NR2B Subtype of The NMDA Receptor Impair Cognition in Multiple Domains

   M. Weed, M. Bookbinder, Joseph L. Polino, Deborah Keavy +7 more

   2016Neuropsychopharmacology24 citations Open access

   Semantic Scholar

   Save

2. The qEEG Signature of Selective NMDA NR2B Negative Allosteric Modulators; A Potential Translational Biomarker for Drug Development

   Deborah Keavy, L. Bristow, D. V. Sivarao, Margaret Batchelder +4 more

   2016PLoS ONE22 citations Open access

   Semantic Scholar

   Save

3. BMS-986163, a Negative Allosteric Modulator of GluN2B with Potential Utility in Major Depressive Disorder.

   L. Marcin, J. Warrier, Srinivasan Thangathirupathy, Jianliang Shi +44 more

   2018ACS Medicinal Chemistry Letters16 citations Open access

   Semantic Scholar

   Save

4. Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-d-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive Disorder

   L. Bristow, Jyoti Gulia, M. Weed, B. Srikumar +40 more

   2017Journal of Pharmacology and Experimental Therapeutics16 citations Open access

   Semantic Scholar

   Save

5. Modulation of Kv11.1 (hERG) channels by 5‐(((1H–indazol‐5‐yl)oxy)methyl)‐N‐(4‐(trifluoromethoxy)phenyl)pyrimidin‐2‐amine (ITP‐2), a novel small molecule activator

   Harinath Sale, Samrat Roy, J. Warrier, Srinivasan Thangathirupathy +4 more

   2017British Journal of Pharmacology10 citations Open access

   Semantic Scholar

   Save

6. Discovery of conformationally rigid 3-azabicyclo[3.1.0]hexane-derived dipeptidyl peptidase-IV inhibitors.

   J. Sattigeri, Murugaiah M. S. Andappan, K. Kishore, Srinivasan Thangathirupathy +6 more

   2008Bioorganic & Medicinal Chemistry Letters8 citations Open access

   Semantic Scholar

   Save